Rare diseases
Investigational molecules
Locations
Study on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome
GreeceStudy Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor
GreeceStudy Comparing Pembrolizumab Alone and with Sacituzumab Govitecan for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels
GreeceStudy on Upadacitinib for Children with Moderate to Severe Ulcerative Colitis
GreeceStudy on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments
GreeceStudy of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery
GreeceStudy on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)
GreeceStudy on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis
GreeceStudy of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema
GreeceLong-Term Study on Aflibercept for Retinopathy of Prematurity in Infants
GreeceStudy of Romiplostim Treatment for Chemotherapy-induced Low Blood Platelets in Adults with Gastrointestinal, Pancreatic, or Colorectal Cancer Receiving Oxaliplatin Chemotherapy
GreeceStudy of Daratumumab Injection for Patients with High-Risk Smoldering Multiple Myeloma
GreeceTell us about your condition – we search every trial in Europe and connect you with the right site.
